PETRI DISH PERSPECTIVES

Send us Fan Mail DISCLAIMER: This is a consistently changing situation. The episode was recorded approximately 4 PM EDT Monday, July 21, 2025.  As of 7.40 PM EDT Monday, July 21, 2025 (Source: Sarepta), "Sarepta Therapeutics notified the U.S. FDA of its decision to voluntarily and temporarily pause all shipments of ELEVIDYS (delandistrogene moxeparvovec) for Duchenne muscular dystrophy in the...

Send us Fan Mail 🔬✨ From Cystic Fibrosis Breakthroughs to Gene Editing Cures In this episode of Petri Dish Perspectives: Biotech Unleashed , Manead unpacks how Vertex turned cystic fibrosis from a fatal disease into a treatable condition and why they’re now tackling sickle cell, diabetes, and more with CRISPR and stem cell science. Discover how visionary chemists, Nobel-winning gene editors, and...

Send us Fan Mail 🧬 From VC to Blockbusters: The Genentech Story In Episode 11 of Petri Dish Perspectives: Biotech Unleashed , host Manead dives into the legendary rise of Genentech, the startup that sparked the biotech revolution. From its humble beginnings in a borrowed lab to pioneering insulin, tPA, Herceptin, and more, learn how Genentech turned recombinant DNA into real-world cures. Discover...

Send us Fan Mail 💡 From Vitamin C to AI-Driven Diagnostics: Roche’s Legacy Unleashed In this episode of Petri Dish Perspectives: Biotech Unleashed , we explore the extraordinary evolution of Roche, from its origins as a 19th-century Swiss chemical company to becoming a global leader in pharmaceuticals and diagnostics. You’ll hear how Roche launched the world’s first branded vitamin C, pioneered m...

Send us Fan Mail 🎧 From Dye Pots to Blockbusters: The Bayer Story In this episode of Petri Dish Perspectives: Biotech Unleashed , host Manead takes you on a journey through Bayer’s 160+ year evolution, from its 1863 roots in coal tar dyes to becoming the maker of Aspirin 💊, Xarelto ❤️, and Eylea 👁️. We explore how a dye salesman and a master dyer built a pharma empire, the game-changing inventio...

Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed , we journey through the 165+ year saga of Bristol Myers Squibb (BMS) — from 19th-century Brooklyn apothecaries and sparkling laxatives 💊 to cutting-edge CAR-T therapies and checkpoint inhibitors in cancer treatment 🧫🔥. Host Manead, a PhD scientist in cancer biology and analytical chemistry, breaks down: 📜 The paral...

Send us Fan Mail Ever wonder how an oil conglomerate helped create one of the world’s top pharma giants? 💥 In this episode of Petri Dish Perspectives: Biotech Unleashed , your host, Manead, dives into the fascinating story of Sanofi , a company whose name you’ve probably seen on insulin pens 💉, flu shots 🦠, and blockbuster immunology meds 💊. We explore:  🔹 Sanofi’s wild beginnings inside a Fr...

Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed , we'll take you on a 350-year journey through the rise of Merck, from its humble beginnings as a family-run pharmacy in 17th-century Germany to becoming one of the world’s most influential pharmaceutical powerhouses. We’ll explore how Merck evolved through groundbreaking discoveries like streptomycin, the MMR vacc...

Send us Fan Mail 🐴 From Farmyard Roots to Pharma Powerhouse: The Boehringer Ingelheim Story 🐴 Welcome to Petri Dish Perspectives: Biotech Unleashed! 🚀 I’m your host, Manead—scientist and biotech nerd. Today, we’re spotlighting Boehringer Ingelheim—a family-owned pharma giant that began in a small German village and grew into one of the world’s top 20 pharmaceutical companies. From veterinary va...

Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed , we dive into the rich history and groundbreaking innovations of Johnson & Johnson (J&J) —one of the most influential healthcare companies in the world. From its origins in the late 19th century as a family-run surgical supply business to becoming a household name with products like Band-Aids , Tylenol , and Jo...

Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed , we explore the rise of AbbVie , a pharmaceutical giant that emerged from Abbott Laboratories in 2013 and quickly became a leader in immunology, oncology, and aesthetics. From its blockbuster drug Humira to major acquisitions like Pharmacyclics and Allergan , AbbVie has strategically expanded its portfolio and global p...

Send us Fan Mail Welcome to Petri Dish Perspectives: Biotech Unleashed ! In this episode, we dive deep into the history and impact of Eli Lilly , a company that began with a small lab in Indianapolis and has grown into the highest market-cap pharmaceutical company in the world . From pioneering insulin production in the 1920s to developing blockbuster drugs like Prozac, Humalog, and Mounjaro , Eli...

Send us Fan Mail 💊 From Brooklyn to Biotech Titan: The Rise of Pfizer 💊 Welcome to the first-ever episode of Petri Dish Perspectives: Biotech Unleashed ! 🚀 I’m your host, Manead—scientist, biotech nerd, and your guide through the fascinating world of life sciences. We’re kicking things off with Pfizer —a company that started as a small chemical business in Brooklyn and grew into a global powerh...